Cargando…

Vitamin D Levels in Women with Polycystic Ovary Syndrome: A Population-Based Study

Background: Conflicting evidence supports a role for vitamin D in women with reproductive disorders such as polycystic ovary syndrome (PCOS) but studies on large, unselected populations have been lacking. Methods: We conducted a general population-based study from the prospective Northern Finland Bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lumme, Johanna, Sebert, Sylvain, Pesonen, Paula, Piltonen, Terhi, Järvelin, Marjo-Riitta, Herzig, Karl-Heinz, Auvinen, Juha, Ojaniemi, Marja, Niinimäki, Maarit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6893754/
https://www.ncbi.nlm.nih.gov/pubmed/31752304
http://dx.doi.org/10.3390/nu11112831
_version_ 1783476272907681792
author Lumme, Johanna
Sebert, Sylvain
Pesonen, Paula
Piltonen, Terhi
Järvelin, Marjo-Riitta
Herzig, Karl-Heinz
Auvinen, Juha
Ojaniemi, Marja
Niinimäki, Maarit
author_facet Lumme, Johanna
Sebert, Sylvain
Pesonen, Paula
Piltonen, Terhi
Järvelin, Marjo-Riitta
Herzig, Karl-Heinz
Auvinen, Juha
Ojaniemi, Marja
Niinimäki, Maarit
author_sort Lumme, Johanna
collection PubMed
description Background: Conflicting evidence supports a role for vitamin D in women with reproductive disorders such as polycystic ovary syndrome (PCOS) but studies on large, unselected populations have been lacking. Methods: We conducted a general population-based study from the prospective Northern Finland Birth Cohort 1966 (NFBC1966). Serum 25-hydroksyvitamin D (25(OH)D) levels were evaluated in women with self-reported PCOS (n = 280) versus non-symptomatic controls (n = 1573) at the age of 31 with wide range of endocrine and metabolic confounders. Results: The levels of 25(OH)D were similar among women with and without self-reported PCOS (50.35 vs. 48.30 nmol/L, p = 0.051). Women with self-reported PCOS presented with a higher body mass index (BMI), increased insulin resistance, and low-grade inflammation and testosterone levels compared to controls. The adjusted linear regression model showed a positive association between total 25(OH)D levels in self-reported PCOS (β = 2.46, 95% confidence interval (CI) 0.84 to 4.08, p = 0.003). The result remained after adjustment for BMI, testosterone, homeostatic model assessment of insulin resistance (HOMA-IR), and high-sensitivity C-reactive protein (hs-CRP) levels. Conclusion: In this population-based setting, PCOS was associated with higher vitamin D levels when adjusting for confounding factors, without distinct beneficial effects on metabolic derangements.
format Online
Article
Text
id pubmed-6893754
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-68937542019-12-23 Vitamin D Levels in Women with Polycystic Ovary Syndrome: A Population-Based Study Lumme, Johanna Sebert, Sylvain Pesonen, Paula Piltonen, Terhi Järvelin, Marjo-Riitta Herzig, Karl-Heinz Auvinen, Juha Ojaniemi, Marja Niinimäki, Maarit Nutrients Article Background: Conflicting evidence supports a role for vitamin D in women with reproductive disorders such as polycystic ovary syndrome (PCOS) but studies on large, unselected populations have been lacking. Methods: We conducted a general population-based study from the prospective Northern Finland Birth Cohort 1966 (NFBC1966). Serum 25-hydroksyvitamin D (25(OH)D) levels were evaluated in women with self-reported PCOS (n = 280) versus non-symptomatic controls (n = 1573) at the age of 31 with wide range of endocrine and metabolic confounders. Results: The levels of 25(OH)D were similar among women with and without self-reported PCOS (50.35 vs. 48.30 nmol/L, p = 0.051). Women with self-reported PCOS presented with a higher body mass index (BMI), increased insulin resistance, and low-grade inflammation and testosterone levels compared to controls. The adjusted linear regression model showed a positive association between total 25(OH)D levels in self-reported PCOS (β = 2.46, 95% confidence interval (CI) 0.84 to 4.08, p = 0.003). The result remained after adjustment for BMI, testosterone, homeostatic model assessment of insulin resistance (HOMA-IR), and high-sensitivity C-reactive protein (hs-CRP) levels. Conclusion: In this population-based setting, PCOS was associated with higher vitamin D levels when adjusting for confounding factors, without distinct beneficial effects on metabolic derangements. MDPI 2019-11-19 /pmc/articles/PMC6893754/ /pubmed/31752304 http://dx.doi.org/10.3390/nu11112831 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lumme, Johanna
Sebert, Sylvain
Pesonen, Paula
Piltonen, Terhi
Järvelin, Marjo-Riitta
Herzig, Karl-Heinz
Auvinen, Juha
Ojaniemi, Marja
Niinimäki, Maarit
Vitamin D Levels in Women with Polycystic Ovary Syndrome: A Population-Based Study
title Vitamin D Levels in Women with Polycystic Ovary Syndrome: A Population-Based Study
title_full Vitamin D Levels in Women with Polycystic Ovary Syndrome: A Population-Based Study
title_fullStr Vitamin D Levels in Women with Polycystic Ovary Syndrome: A Population-Based Study
title_full_unstemmed Vitamin D Levels in Women with Polycystic Ovary Syndrome: A Population-Based Study
title_short Vitamin D Levels in Women with Polycystic Ovary Syndrome: A Population-Based Study
title_sort vitamin d levels in women with polycystic ovary syndrome: a population-based study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6893754/
https://www.ncbi.nlm.nih.gov/pubmed/31752304
http://dx.doi.org/10.3390/nu11112831
work_keys_str_mv AT lummejohanna vitamindlevelsinwomenwithpolycysticovarysyndromeapopulationbasedstudy
AT sebertsylvain vitamindlevelsinwomenwithpolycysticovarysyndromeapopulationbasedstudy
AT pesonenpaula vitamindlevelsinwomenwithpolycysticovarysyndromeapopulationbasedstudy
AT piltonenterhi vitamindlevelsinwomenwithpolycysticovarysyndromeapopulationbasedstudy
AT jarvelinmarjoriitta vitamindlevelsinwomenwithpolycysticovarysyndromeapopulationbasedstudy
AT herzigkarlheinz vitamindlevelsinwomenwithpolycysticovarysyndromeapopulationbasedstudy
AT auvinenjuha vitamindlevelsinwomenwithpolycysticovarysyndromeapopulationbasedstudy
AT ojaniemimarja vitamindlevelsinwomenwithpolycysticovarysyndromeapopulationbasedstudy
AT niinimakimaarit vitamindlevelsinwomenwithpolycysticovarysyndromeapopulationbasedstudy